Target
5-hydroxytryptamine receptor 5A
Ligand
BDBM50122872
Substrate
n/a
Ki
>10000±n/a nM
Comments
PDSP_1544
Citation
 Briejer, MRBosmans, JPVan Daele, PJurzak, MHeylen, LLeysen, JEPrins, NHSchuurkes, JA The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 423:71-83 (2001) [PubMed]  Article
Target
Name:
5-hydroxytryptamine receptor 5A
Synonyms:
5-HT-5 | 5-HT-5A | 5-hydroxytryptamine receptor 5 (5-HT5) | 5-hydroxytryptamine receptor 5A (5-HT5A) | 5HT5A_HUMAN | HTR5A | Serotonin (5-HT) receptor | Serotonin receptor 5A
Type:
Enzyme
Mol. Mass.:
40266.25
Organism:
Homo sapiens (Human)
Description:
P47898
Residue:
357
Sequence:
MDLPVNLTSFSLSTPSPLETNHSLGKDDLRPSSPLLSVFGVLILTLLGFLVAATFAWNLLVLATILRVRTFHRVPHNLVASMAVSDVLVAALVMPLSLVHELSGRRWQLGRRLCQLWIACDVLCCTASIWNVTAIALDRYWSITRHMEYTLRTRKCVSNVMIALTWALSAVISLAPLLFGWGETYSEGSEECQVSREPSYAVFSTVGAFYLPLCVVLFVYWKIYKAAKFRVGSRKTNSVSPISEAVEVKDSAKQPQMVFTVRHATVTFQPEGDTWREQKEQRAALMVGILIGVFVLCWIPFFLTELISPLCSCDIPAIWKSIFLWLGYSNSFFNPLIYTAFNKNYNSAFKNFFSRQH
  
Inhibitor
Name:
BDBM50122872
Synonyms:
4-Amino-5-chloro-2,3-dihydro-benzofuran-7-carboxylic acid [1-(3-methoxy-propyl)-piperidin-4-yl]-amide | CHEMBL117287 | PRUCALOPRIDE | US9663465, prucalopride
Type:
Small organic molecule
Emp. Form.:
C18H26ClN3O3
Mol. Mass.:
367.87
SMILES:
COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12
Structure:
Search PDB for entries with ligand similarity: